Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningiomaXin Tang, Liangxue Zhou, Shuangming Fan et al.|Clinical & Translational Immunology|2020Cited by 75
Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacyCheng Huang, Gang Guo, Hongjian Li et al.|Theranostics|2020Cited by 22
T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFvKunhong Zhong, Aiping Tong, Zhiyong Liu et al.|Aging|2020Cited by 6